Pomalidomide Capsule
Product Images NDC 70095-057

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Pomalidomide (NDC 70095-057). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pomalidomide-1mg (Pomalidomide 1mg)

Pomalidomide Capsules 1 mg oral dosage label from Sun Pharmaceutical Industries, Inc. The label indicates prescription-only status, package contains 21 capsules, with a warning about potential human birth defects. The label includes storage instructions, distributor and manufacturer information, a barcode, and serialized coding for product traceability.*

FDA Label Image

Pomalidomide-2mg (Pomalidomide 2mg)

Pomalidomide Capsules 2 mg label by Sun Pharmaceutical Industries, Inc. The label indicates a 21-capsule package and includes a warning about potential human birth defects. It provides drug strength and basic handling instructions, noting the capsules are child-resistant and the storage temperature range. Manufacturing information shows origin from Synthon Hispania, Barcelona, Spain.*

FDA Label Image

Pomalidomide-3mg (Pomalidomide 3mg)

Pomalidomide Capsules 3 mg label for a 21-capsule package by Sun Pharmaceutical Industries, Inc. The label includes a black box warning for potential human birth defects, patient and pharmacist instructions, storage conditions, and distributor information for Sun Pharmaceutical Inc., Cranbury, NJ. Manufactured by Synthon Hispania in Barcelona, Spain. The label displays NDC 70095-059-01 and a barcode.*

FDA Label Image

Pomalidomide-4mg (Pomalidomide 4mg)

Pomalidomide Capsules 4 mg oral dosage packaging label from Sun Pharmaceutical Industries, Inc. The label indicates 21 capsules per package, highlighting a warning about potential for human birth defects. It includes storage instructions, a barcode, handling notes, and manufacturing details from Synthon Hispania, Barcelona, Spain.*

FDA Label Image

Pomalidomide-fig 1 (Pomalidomide Fig 1)

A Kaplan-Meier plot depicting progression-free survival over months for two treatment groups: HD-DEX (solid line) and POM+LD-DEX (dashed line). The vertical axis shows the proportion of subjects surviving without progression, and the horizontal axis shows time in months. A table below the graph lists the number of subjects at risk over time for each group.*

FDA Label Image

Pomalidomide-fig 2 (Pomalidomide Fig 2)

A survival curve graph comparing overall survival over months between two treatment groups: HD-DEX and POM+LD-DEX. The y-axis represents the proportion of subjects surviving, and the x-axis shows time in months. Data points and survival lines are plotted, with sample sizes decreasing over time.*

FDA Label Image

Pomalidomide-str (Pomalidomide Str)

Chemical structure of pomalidomide, showing its molecular framework with key functional groups including an amine, imide, and lactam rings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.